Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37781363)

  • 1. Deciphering the mechanism of
    Gu J; Lv X; Li W; Li G; He X; Zhang Y; Shi L; Zhang X
    Front Immunol; 2023; 14():1230681. PubMed ID: 37781363
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity.
    Long X; Wong CC; Tong L; Chu ESH; Ho Szeto C; Go MYY; Coker OO; Chan AWH; Chan FKL; Sung JJY; Yu J
    Nat Microbiol; 2019 Dec; 4(12):2319-2330. PubMed ID: 31501538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice.
    Liu Y; Wong CC; Ding Y; Gao M; Wen J; Lau HC; Cheung AH; Huang D; Huang H; Yu J
    Nat Microbiol; 2024 May; ():. PubMed ID: 38750176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.
    Tsoi H; Chu ESH; Zhang X; Sheng J; Nakatsu G; Ng SC; Chan AWH; Chan FKL; Sung JJY; Yu J
    Gastroenterology; 2017 May; 152(6):1419-1433.e5. PubMed ID: 28126350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
    Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
    Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
    Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
    Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
    Rokavec M; Bouznad N; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
    Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
    Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
    Liu Z; Xie Y; Xiong Y; Liu S; Qiu C; Zhu Z; Mao H; Yu M; Wang X
    Cancer Lett; 2020 Jan; 469():173-185. PubMed ID: 31629935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.
    Fan F; Samuel S; Evans KW; Lu J; Xia L; Zhou Y; Sceusi E; Tozzi F; Ye XC; Mani SA; Ellis LM
    Cancer Med; 2012 Aug; 1(1):5-16. PubMed ID: 23342249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer.
    Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.